Geode Capital Management LLC Buys 16,596 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Geode Capital Management LLC lifted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCOFree Report) by 0.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,467,769 shares of the company’s stock after acquiring an additional 16,596 shares during the quarter. Geode Capital Management LLC owned about 1.83% of AdaptHealth worth $23,499,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Segall Bryant & Hamill LLC boosted its position in AdaptHealth by 29.8% during the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company’s stock worth $45,734,000 after purchasing an additional 1,102,173 shares during the period. KLP Kapitalforvaltning AS bought a new stake in shares of AdaptHealth during the 4th quarter worth $169,000. Sei Investments Co. grew its stake in AdaptHealth by 8.5% in the 4th quarter. Sei Investments Co. now owns 366,246 shares of the company’s stock valued at $3,487,000 after buying an additional 28,633 shares during the last quarter. American Century Companies Inc. lifted its position in AdaptHealth by 30.2% during the 4th quarter. American Century Companies Inc. now owns 210,359 shares of the company’s stock worth $2,003,000 after acquiring an additional 48,736 shares during the last quarter. Finally, Teacher Retirement System of Texas boosted its holdings in AdaptHealth by 134.1% during the fourth quarter. Teacher Retirement System of Texas now owns 45,225 shares of the company’s stock valued at $431,000 after acquiring an additional 25,909 shares during the period. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Price Performance

Shares of AdaptHealth stock opened at $7.79 on Friday. AdaptHealth Corp. has a 1-year low of $7.72 and a 1-year high of $11.90. The firm’s 50-day moving average price is $9.70 and its two-hundred day moving average price is $9.97. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The stock has a market capitalization of $1.05 billion, a price-to-earnings ratio of -4.72, a P/E/G ratio of 1.08 and a beta of 1.44.

Analysts Set New Price Targets

Several research firms recently commented on AHCO. Truist Financial upped their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Royal Bank of Canada lifted their price objective on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. Robert W. Baird increased their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. UBS Group cut their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Finally, Canaccord Genuity Group upped their price objective on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, AdaptHealth has a consensus rating of “Buy” and a consensus target price of $13.80.

Read Our Latest Analysis on AdaptHealth

AdaptHealth Company Profile

(Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Recommended Stories

Institutional Ownership by Quarter for AdaptHealth (NASDAQ:AHCO)

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.